Pill Identifier Mydayis - NDC 54092-474
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, And Amphetamine Sulfate
Product Code 54092-474
Mydayis by Takeda Pharmaceuticals America, Inc. is a brown and white capsule capsule extended release about 19 mm in size, imprinted with shire;465;37;5mg. The product is a human prescription drug with active ingredient(s) dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate.
Mydayis
Active Ingredient(s): Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, And Amphetamine Sulfate
Inactive Ingredient(s):
- GELATIN, UNSPECIFIED
- HYPROMELLOSE, UNSPECIFIED
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
- POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1
- 280000 MW)
- SUCROSE
- TALC
- TRIETHYL CITRATE
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- TITANIUM DIOXIDE
Takeda Pharmaceuticals America, Inc.
Product Type: Human Prescription Drug
Dosage Form: Capsule, Extended Release
- Brown (C48332)
- White (C48325)
DEA Schedule: CII
Product Packages
NDC Package Code | Package Description |
---|---|
54092-474-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.